The Lung Lab

When diagnosing rare lung disease, the human eye can only see so much. But with artificial intelligence, patterns in medical imaging that were previously invisible suddenly become clear.  In this episode, host Elizabeth Estes sits down with Dr. Helmut Prosch to explore the transformative role of artificial intelligence in diagnosing rare and fibrosing lung diseases. Dr. Prosch is the President of...

In rare lung disease, more data isn't always better. Good data is all about impact. In this episode, host Elizabeth Estes sits down with Sandra Stapleton, Chief Operating Officer of Vida, a data platform that combines high-quality imaging with AI to accelerate development of life-saving therapies. They discuss the importance of combining imaging with clinical data, the challenges of unifying data...

Bronchiectasis is having a moment in pulmonary medicine. After many years of research and patient data, our understanding of bronchiectasis has finally reached a point where the future of bronchiectasis treatment is ready to be considered. In this episode, rare lung disease expert Dr. Marion Wencker joins host Elizabeth Estes to explain why bronchiectasis finds itself in a similar position to wher...

Dr. Lisa Lancaster is one of pulmonology's brightest stars. She's both the Director of the Interstitial Lung Disease (ILD) Program at Vanderbilt University and Chief Medical Officer at Endeavor Biometrics. A pulmonologist with over 25 years of experience and 85 clinical trials behind her, she's one of the most respected voices in interstitial lung disease.  In this episode, Dr. Lancaster sits down...

What if we could detect lung disease years earlier than we thought possible? What if we could bring together fierce competitors to transform lung disease care for good? Welcome to  The Lung Lab , a podcast exploring how we are redefining rare and progressive lung disease. Hosted by Elizabeth Estes, Executive Director of the Open Source Imaging Consortium (OSIC), the series brings together the lead...